IP Library › Granted Patent US 7,960,564
Granted Patent B2
US 7,960,564 · App. 12/251,893 · Granted Jun 14, 2011

Crystalline chemotherapeutic

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,960,564
App. No.
12/251,893
Granted
Jun 14, 2011
Kind
B2
Abstract

N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Crystalline Form 1, ways to make it, formulations comprising it and made with it and methods of treating patients having disease using it are disclosed.

Claims (1)

1. N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea Crystalline Form 1 which, when measured at about 25° C. with radiation at a wavelength of 1.54178 Å, is characterized by a powder diffraction pattern having respective 2θ values of about 7.8°, 9.1°, 11.0°, 11.8°, and 12.1°.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2013
From: ABBOTT LABORATORIES
To: ABBVIE INC.
Reel/Frame 030237/0588 →
CORRECTIVE ASSIGNMENT TO CORRECT THE <CONVEYING PARTIES> PREVIOUSLY RECORDED ON REEL 022153 FRAME 0876. ASSIGNOR(S) HEREBY CONFIRMS THE REMOVE <THOMAS B. BORCHARDT> ADD <MICHAEL J. ROZEMA>. Recorded May 18, 2010
From: ROZEMA, MICHAEL J.
To: ABBOTT LABORATORIES
Reel/Frame 024400/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2009
From: BORCHARDT, THOMAS B.
To: ABBOTT LABORATORIES
Reel/Frame 022153/0876 →